EDAP EDAP TMS SA

Halliburton Investor Relations Retained as Counsel to EDAP TMS S.A.; Company to Begin Enhanced Shareholder Communications and Outreach Program DALLAS, Feb. 7 /PRNewswire/ -- EDAP TMS S.A. (NASDAQ:EDAP), has retained Halliburton Investor Relations to assist the company in its efforts to communicate with the investment community. EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically proven choice for High Intensity Focused Ultrasound (HIFU) treatment of localized prostate cancer. HIFU treatment is shown to be a minimally invasive and effective treatment option with a low occurrence of side effects. The company is also developing this technology for the treatment of certain other types of tumors. EDAP TMS S.A. also produces and commercializes medical equipment for treatment of urinary tract stones using Extra-corporeal Shockwave Lithotripsy (ESWL). Based in Dallas, Texas, Halliburton Investor Relations was formed in 1990 to provide a superior caliber of investor relations representation to publicly traded companies. The firm develops strategic communications programs designed to cultivate highly targeted relationships in the financial community and improve the visibility of successful public companies to investors. For more information, visit the company's Web site at http://www.halliburtonir.com/ . For more information on the Company, contact Halliburton Investor Relations by phone at 972-458-8000 or see the Investor Relations Section at: http://www.edap-tms.com/ . This press release contains, in addition to historical information, forward-looking statements that involve risks and uncertainties. These include statements regarding the Company's growth and expansion plans. Such statements are based on management's current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that may cause such a difference include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission. DATASOURCE: Halliburton Investor Relations CONTACT: Matt Kreps, or Geralyn DeBusk, both of Halliburton Investor Relations, +1-972-458-8000 Web site: http://www.halliburtonir.com/ http://www.edap-tms.com/ Company News On-Call: http://www.prnewswire.com/comp/133897.html

Copyright